Wang et al. demonstrated that Amygdalin reduces the phosphorylation of JAK2 and STAT3 and the levels of IFN-γ and TNF-α in HBV-associated liver cancer, thereby weakening the viability, invasion and migration of tumor cells [51]. This evidence concerns the gene JAK2 and liver cancer.